NASDAQ: $NKTR SAN FRANCISCO, Aug. 28, 2026 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced that, on August 20, 2026, the Organization and Compensation Committee of Nektar’s Board of Directors granted non-qualified stock options to purchase an aggregate of 25,200 shares of its common… Source: Read More